The Role of Imaging in Testicular Cancer Diagnosis, Staging and Follow-up
Journal Title: Üroonkoloji Bülteni - Year 2017, Vol 16, Issue 2
Abstract
Although testicular cancer is relatively rare and accounting for approximately 1-1.5% of all cancers in men, it is the most frequent malignancy in young men. Testicular cancer can manifest in a variety of ways. A painless scrotal mass is the most common manifestation of it. Ultrasonography is frequently used, and should always be the initial imaging modality in assessing patients with scrotal masses. Computed tomography and magnetic resonance imaging are used for staging and follow-up of testicular cancer. Radiologists play an important role in diagnosis, staging, and follow-up of testicular cancers. In this review, we aim to describe the imaging findings.
Authors and Affiliations
Nuray Voyvoda, Bekir Voyvoda, Özden Çamurdan
Robotic-assisted Laparoscopic Prostatectomy: Initial Experience of 267 Cases
Objective: To present our experience of 267 consecutive patients treated with robotic-assisted laparoscopic prostatectomy (RALP) and assess the perioperative and postoperative outcomes. Materials and Methods: Materials a...
The Relationship between Bladder Cancer and Epigenetic Alterations
Bladder cancer is one of the most common cancers of urinary system and approximately 70% of the cases are low grade and non-muscle invasive. Because of the histological indicator inadequacy of heterogeneous tumors like b...
Predictive Value of Hormonal Evaluation Before Prostate Needle Biopsy on Prostate Cancer T Stage and Prognosis
Objective: In this study we evaluated the hormone data before prostate needle biopsy (PNB) in patients who underwent retropubic radical prostatectomy (RRP) due to prostate adenocarcinoma (PCa). Correlations between the p...
Neutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Report
Prostate cancer is one of the most common tumors in men. Docetaxel and prednisone treatment are accepted as standard therapy in castration-resistant prostate cancer patients. Docetaxel is a chemotherapeutic drug of the t...
Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation
Intravesical bacillus Calmette-Guerin (BCG) therapy is the gold standard treatment option in high-risk non-invasive bladder cancer. However, BCG is a very toxic agent. A significant proportion of patients have BCG intole...